| |
|
|
Recommendations - Pneumococcal |
|
|
|
Use of 13-Valent Pneumococcal
Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide
Vaccine for Adults with Immunocompromising Conditions:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP)
Source: MMWR, October 12,
2012; 61(40):816-9 |
|
|
HTML | PDF |
| |
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5 |
|
|
HTML | PDF |
| |
Prevention of
Pneumococcal Disease Among Infants and Children--Use of 13-Valent
Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal
Polysaccharide Vaccine
Source: MMWR, December 10,
2010; 59(RR11):1-18 |
|
|
HTML | PDF |
| |
Updated ACIP
Recommendations: Prevention of Invasive Pneumococcal Disease Among
Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine
(PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6 |
|
|
HTML | PDF |
| |
Licensure of a 13-Valent
Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use
Among Children --- Advisory Committee on Immunization Practices
(ACIP), 2010
Source: MMWR, March 12, 2010;
59(09):258-261 |
|
|
HTML | PDF |
| |
Updated Recommendation from the
Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent
Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who
Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344 |
|
|
HTML | PDF |
| |
Pneumococcal Vaccination for Cochlear
Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2 |
|
|
HTML | PDF |
| |
Preventing
Pneumococcal Disease Among Infants and Young Children
Source: MMWR
October 6, 2000 / Vol. 49 / No. RR-09 |
|
|
HTML | PDF |
| |
Prevention of
Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08 |
|
|
HTML | PDF |
|
| This page was reviewed
on October 12, 2012 |
A-Z
IAC Home